GABA受容体アゴニスト薬の世界市場（～2026年）

• 英文タイトル：Global GABA Receptor Agonist Drug Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY06659 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はGABA受容体アゴニスト薬のグローバル市場について調査・分析したレポートです。種類別（バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロノピン（クロナゼパム）、ティアグビン）市場規模、用途別（注意欠陥多動性障害（ADHD）、精神障害・うつ病、アルツハイマー、てんかん・発作、不安・睡眠障害、肥満・アルコール依存症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別GABA受容体アゴニスト薬の競争状況、市場シェア ・世界のGABA受容体アゴニスト薬市場：種類別市場規模 2015年-2020年（バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロノピン（クロナゼパム）、ティアグビン） ・世界のGABA受容体アゴニスト薬市場：種類別市場規模予測 2021年-2026年（バマルゾール、フェニバット、バクロフェン、ガボクサドール、クロノピン（クロナゼパム）、ティアグビン） ・世界のGABA受容体アゴニスト薬市場：用途別市場規模 2015年-2020年（注意欠陥多動性障害（ADHD）、精神障害・うつ病、アルツハイマー、てんかん・発作、不安・睡眠障害、肥満・アルコール依存症） ・世界のGABA受容体アゴニスト薬市場：用途別市場規模予測 2021年-2026年（注意欠陥多動性障害（ADHD）、精神障害・うつ病、アルツハイマー、てんかん・発作、不安・睡眠障害、肥満・アルコール依存症） ・北米のGABA受容体アゴニスト薬市場分析：米国、カナダ ・ヨーロッパのGABA受容体アゴニスト薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのGABA受容体アゴニスト薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のGABA受容体アゴニスト薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのGABA受容体アゴニスト薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advicenne、AstraZeneca、Athena Drug Delivery Solutions、Biocodex、Elan Corporation、Eli Lilly and Company、H.LundBeck, Merck and Co、GlaxoSmithKline、NovaDel Pharma、Novartis、OVATION Pharmaceuticals、Osmotica Pharmaceutical、Pfizer、sanofi-aventis、VIVUS、XenoPort ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global GABA Receptor Agonist Drug Market
The global GABA Receptor Agonist Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global GABA Receptor Agonist Drug Scope and Market Size
GABA Receptor Agonist Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global GABA Receptor Agonist Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the GABA Receptor Agonist Drug market is segmented into
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine

Segment by Application, the GABA Receptor Agonist Drug market is segmented into
Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism

Regional and Country-level Analysis
The GABA Receptor Agonist Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the GABA Receptor Agonist Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and GABA Receptor Agonist Drug Market Share Analysis
GABA Receptor Agonist Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in GABA Receptor Agonist Drug business, the date to enter into the GABA Receptor Agonist Drug market, GABA Receptor Agonist Drug product introduction, recent developments, etc.

The major vendors covered:
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort

レポート目次

---

1 Study Coverage
1.1 GABA Receptor Agonist Drug Product Introduction
1.2 Market Segments
1.3 Key GABA Receptor Agonist Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Type
1.4.2 Bamaluzole
1.4.3 Phenibut
1.4.4 Baclofen
1.4.5 Gaboxadol
1.4.6 Klonopin (clonazepam)
1.4.7 Tiagbine
1.5 Market by Application
1.5.1 Global GABA Receptor Agonist Drug Market Size Growth Rate by Application
1.5.2 Attention Deficit Hyperactivity Disorder (ADHD)
1.5.3 Psychiatric Disorders and Depression
1.5.4 Alzheimer
1.5.5 Epilepsy and Seizure
1.5.6 Anxiety and Sleep Disorders
1.5.7 Obesity and Alcoholism
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global GABA Receptor Agonist Drug Market Size, Estimates and Forecasts
2.1.1 Global GABA Receptor Agonist Drug Revenue 2015-2026
2.1.2 Global GABA Receptor Agonist Drug Sales 2015-2026
2.2 Global GABA Receptor Agonist Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global GABA Receptor Agonist Drug Competitor Landscape by Players
3.1 GABA Receptor Agonist Drug Sales by Manufacturers
3.1.1 GABA Receptor Agonist Drug Sales by Manufacturers (2015-2020)
3.1.2 GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2015-2020)
3.2 GABA Receptor Agonist Drug Revenue by Manufacturers
3.2.1 GABA Receptor Agonist Drug Revenue by Manufacturers (2015-2020)
3.2.2 GABA Receptor Agonist Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global GABA Receptor Agonist Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by GABA Receptor Agonist Drug Revenue in 2019
3.2.5 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 GABA Receptor Agonist Drug Price by Manufacturers
3.4 GABA Receptor Agonist Drug Manufacturing Base Distribution, Product Types
3.4.1 GABA Receptor Agonist Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers GABA Receptor Agonist Drug Product Type
3.4.3 Date of International Manufacturers Enter into GABA Receptor Agonist Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global GABA Receptor Agonist Drug Market Size by Type (2015-2020)
4.1.1 Global GABA Receptor Agonist Drug Sales by Type (2015-2020)
4.1.2 Global GABA Receptor Agonist Drug Revenue by Type (2015-2020)
4.1.3 GABA Receptor Agonist Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global GABA Receptor Agonist Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Type (2021-2026)
4.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Type (2021-2026)
4.2.3 GABA Receptor Agonist Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global GABA Receptor Agonist Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global GABA Receptor Agonist Drug Market Size by Application (2015-2020)
5.1.1 Global GABA Receptor Agonist Drug Sales by Application (2015-2020)
5.1.2 Global GABA Receptor Agonist Drug Revenue by Application (2015-2020)
5.1.3 GABA Receptor Agonist Drug Price by Application (2015-2020)
5.2 GABA Receptor Agonist Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global GABA Receptor Agonist Drug Sales Forecast by Application (2021-2026)
5.2.2 Global GABA Receptor Agonist Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global GABA Receptor Agonist Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America GABA Receptor Agonist Drug by Country
6.1.1 North America GABA Receptor Agonist Drug Sales by Country
6.1.2 North America GABA Receptor Agonist Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America GABA Receptor Agonist Drug Market Facts & Figures by Type
6.3 North America GABA Receptor Agonist Drug Market Facts & Figures by Application

7 Europe
7.1 Europe GABA Receptor Agonist Drug by Country
7.1.1 Europe GABA Receptor Agonist Drug Sales by Country
7.1.2 Europe GABA Receptor Agonist Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe GABA Receptor Agonist Drug Market Facts & Figures by Type
7.3 Europe GABA Receptor Agonist Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific GABA Receptor Agonist Drug by Region
8.1.1 Asia Pacific GABA Receptor Agonist Drug Sales by Region
8.1.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific GABA Receptor Agonist Drug Market Facts & Figures by Type
8.3 Asia Pacific GABA Receptor Agonist Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America GABA Receptor Agonist Drug by Country
9.1.1 Latin America GABA Receptor Agonist Drug Sales by Country
9.1.2 Latin America GABA Receptor Agonist Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America GABA Receptor Agonist Drug Market Facts & Figures by Type
9.3 Central & South America GABA Receptor Agonist Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa GABA Receptor Agonist Drug by Country
10.1.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Country
10.1.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa GABA Receptor Agonist Drug Market Facts & Figures by Type
10.3 Middle East and Africa GABA Receptor Agonist Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Advicenne
11.1.1 Advicenne Corporation Information
11.1.2 Advicenne Description and Business Overview
11.1.3 Advicenne Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
11.1.5 Advicenne Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca GABA Receptor Agonist Drug Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Athena Drug Delivery Solutions
11.3.1 Athena Drug Delivery Solutions Corporation Information
11.3.2 Athena Drug Delivery Solutions Description and Business Overview
11.3.3 Athena Drug Delivery Solutions Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Products Offered
11.3.5 Athena Drug Delivery Solutions Related Developments
11.4 Biocodex
11.4.1 Biocodex Corporation Information
11.4.2 Biocodex Description and Business Overview
11.4.3 Biocodex Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biocodex GABA Receptor Agonist Drug Products Offered
11.4.5 Biocodex Related Developments
11.5 Elan Corporation
11.5.1 Elan Corporation Corporation Information
11.5.2 Elan Corporation Description and Business Overview
11.5.3 Elan Corporation Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Elan Corporation GABA Receptor Agonist Drug Products Offered
11.5.5 Elan Corporation Related Developments
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Corporation Information
11.6.2 Eli Lilly and Company Description and Business Overview
11.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Products Offered
11.6.5 Eli Lilly and Company Related Developments
11.7 H.LundBeck, Merck and Co
11.7.1 H.LundBeck, Merck and Co Corporation Information
11.7.2 H.LundBeck, Merck and Co Description and Business Overview
11.7.3 H.LundBeck, Merck and Co Sales, Revenue and Gross Margin (2015-2020)
11.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Products Offered
11.7.5 H.LundBeck, Merck and Co Related Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description and Business Overview
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Products Offered
11.8.5 GlaxoSmithKline Related Developments
11.9 NovaDel Pharma
11.9.1 NovaDel Pharma Corporation Information
11.9.2 NovaDel Pharma Description and Business Overview
11.9.3 NovaDel Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 NovaDel Pharma GABA Receptor Agonist Drug Products Offered
11.9.5 NovaDel Pharma Related Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description and Business Overview
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis GABA Receptor Agonist Drug Products Offered
11.10.5 Novartis Related Developments
11.1 Advicenne
11.1.1 Advicenne Corporation Information
11.1.2 Advicenne Description and Business Overview
11.1.3 Advicenne Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
11.1.5 Advicenne Related Developments
11.12 Osmotica Pharmaceutical
11.12.1 Osmotica Pharmaceutical Corporation Information
11.12.2 Osmotica Pharmaceutical Description and Business Overview
11.12.3 Osmotica Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Osmotica Pharmaceutical Products Offered
11.12.5 Osmotica Pharmaceutical Related Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Description and Business Overview
11.13.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pfizer Products Offered
11.13.5 Pfizer Related Developments
11.14 sanofi-aventis
11.14.1 sanofi-aventis Corporation Information
11.14.2 sanofi-aventis Description and Business Overview
11.14.3 sanofi-aventis Sales, Revenue and Gross Margin (2015-2020)
11.14.4 sanofi-aventis Products Offered
11.14.5 sanofi-aventis Related Developments
11.15 VIVUS
11.15.1 VIVUS Corporation Information
11.15.2 VIVUS Description and Business Overview
11.15.3 VIVUS Sales, Revenue and Gross Margin (2015-2020)
11.15.4 VIVUS Products Offered
11.15.5 VIVUS Related Developments
11.16 XenoPort
11.16.1 XenoPort Corporation Information
11.16.2 XenoPort Description and Business Overview
11.16.3 XenoPort Sales, Revenue and Gross Margin (2015-2020)
11.16.4 XenoPort Products Offered
11.16.5 XenoPort Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 GABA Receptor Agonist Drug Market Estimates and Projections by Region
12.1.1 Global GABA Receptor Agonist Drug Sales Forecast by Regions 2021-2026
12.1.2 Global GABA Receptor Agonist Drug Revenue Forecast by Regions 2021-2026
12.2 North America GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
12.2.1 North America: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
12.2.2 North America: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
12.2.3 North America: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
12.3 Europe GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
12.3.1 Europe: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
12.3.2 Europe: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
12.3.3 Europe: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: GABA Receptor Agonist Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
12.5.2 Latin America: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa GABA Receptor Agonist Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: GABA Receptor Agonist Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: GABA Receptor Agonist Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: GABA Receptor Agonist Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key GABA Receptor Agonist Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 GABA Receptor Agonist Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. GABA Receptor Agonist Drug Market Segments
Table 2. Ranking of Global Top GABA Receptor Agonist Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global GABA Receptor Agonist Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Bamaluzole
Table 5. Major Manufacturers of Phenibut
Table 6. Major Manufacturers of Baclofen
Table 7. Major Manufacturers of Gaboxadol
Table 8. Major Manufacturers of Klonopin (clonazepam)
Table 9. Major Manufacturers of Tiagbine
Table 10. Global GABA Receptor Agonist Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global GABA Receptor Agonist Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global GABA Receptor Agonist Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global GABA Receptor Agonist Drug Sales Market Share by Regions (2015-2020)
Table 14. Global GABA Receptor Agonist Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global GABA Receptor Agonist Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global GABA Receptor Agonist Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global GABA Receptor Agonist Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA Receptor Agonist Drug as of 2019)
Table 19. GABA Receptor Agonist Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. GABA Receptor Agonist Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers GABA Receptor Agonist Drug Price (2015-2020) (USD/Pcs)
Table 22. GABA Receptor Agonist Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers GABA Receptor Agonist Drug Product Type
Table 24. Date of International Manufacturers Enter into GABA Receptor Agonist Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global GABA Receptor Agonist Drug Sales Share by Type (2015-2020)
Table 28. Global GABA Receptor Agonist Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global GABA Receptor Agonist Drug Revenue Share by Type (2015-2020)
Table 30. GABA Receptor Agonist Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global GABA Receptor Agonist Drug Sales Share by Application (2015-2020)
Table 33. North America GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 35. North America GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 37. North America GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Table 39. North America GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Table 41. Europe GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 43. Europe GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Table 47. Europe GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific GABA Receptor Agonist Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific GABA Receptor Agonist Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific GABA Receptor Agonist Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa GABA Receptor Agonist Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa GABA Receptor Agonist Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa GABA Receptor Agonist Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Table 73. Advicenne Corporation Information
Table 74. Advicenne Description and Major Businesses
Table 75. Advicenne GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Advicenne Product
Table 77. Advicenne Recent Development
Table 78. AstraZeneca Corporation Information
Table 79. AstraZeneca Description and Major Businesses
Table 80. AstraZeneca GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. AstraZeneca Product
Table 82. AstraZeneca Recent Development
Table 83. Athena Drug Delivery Solutions Corporation Information
Table 84. Athena Drug Delivery Solutions Description and Major Businesses
Table 85. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Athena Drug Delivery Solutions Product
Table 87. Athena Drug Delivery Solutions Recent Development
Table 88. Biocodex Corporation Information
Table 89. Biocodex Description and Major Businesses
Table 90. Biocodex GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Biocodex Product
Table 92. Biocodex Recent Development
Table 93. Elan Corporation Corporation Information
Table 94. Elan Corporation Description and Major Businesses
Table 95. Elan Corporation GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Elan Corporation Product
Table 97. Elan Corporation Recent Development
Table 98. Eli Lilly and Company Corporation Information
Table 99. Eli Lilly and Company Description and Major Businesses
Table 100. Eli Lilly and Company GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Eli Lilly and Company Product
Table 102. Eli Lilly and Company Recent Development
Table 103. H.LundBeck, Merck and Co Corporation Information
Table 104. H.LundBeck, Merck and Co Description and Major Businesses
Table 105. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. H.LundBeck, Merck and Co Product
Table 107. H.LundBeck, Merck and Co Recent Development
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Recent Development
Table 113. NovaDel Pharma Corporation Information
Table 114. NovaDel Pharma Description and Major Businesses
Table 115. NovaDel Pharma GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. NovaDel Pharma Product
Table 117. NovaDel Pharma Recent Development
Table 118. Novartis Corporation Information
Table 119. Novartis Description and Major Businesses
Table 120. Novartis GABA Receptor Agonist Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Novartis Product
Table 122. Novartis Recent Development
Table 123. OVATION Pharmaceuticals Corporation Information
Table 124. OVATION Pharmaceuticals Description and Major Businesses
Table 125. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. OVATION Pharmaceuticals Product
Table 127. OVATION Pharmaceuticals Recent Development
Table 128. Osmotica Pharmaceutical Corporation Information
Table 129. Osmotica Pharmaceutical Description and Major Businesses
Table 130. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Osmotica Pharmaceutical Product
Table 132. Osmotica Pharmaceutical Recent Development
Table 133. Pfizer Corporation Information
Table 134. Pfizer Description and Major Businesses
Table 135. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 136. Pfizer Product
Table 137. Pfizer Recent Development
Table 138. sanofi-aventis Corporation Information
Table 139. sanofi-aventis Description and Major Businesses
Table 140. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 141. sanofi-aventis Product
Table 142. sanofi-aventis Recent Development
Table 143. VIVUS Corporation Information
Table 144. VIVUS Description and Major Businesses
Table 145. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 146. VIVUS Product
Table 147. VIVUS Recent Development
Table 148. XenoPort Corporation Information
Table 149. XenoPort Description and Major Businesses
Table 150. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 151. XenoPort Product
Table 152. XenoPort Recent Development
Table 153. Global GABA Receptor Agonist Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 154. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Regions (2021-2026)
Table 155. Global GABA Receptor Agonist Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 156. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 157. North America: GABA Receptor Agonist Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 158. North America: GABA Receptor Agonist Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 159. Europe: GABA Receptor Agonist Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 160. Europe: GABA Receptor Agonist Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 161. Asia Pacific: GABA Receptor Agonist Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 162. Asia Pacific: GABA Receptor Agonist Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 163. Latin America: GABA Receptor Agonist Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 164. Latin America: GABA Receptor Agonist Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 165. Middle East and Africa: GABA Receptor Agonist Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 166. Middle East and Africa: GABA Receptor Agonist Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 167. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 168. Key Challenges
Table 169. Market Risks
Table 170. Main Points Interviewed from Key GABA Receptor Agonist Drug Players
Table 171. GABA Receptor Agonist Drug Customers List
Table 172. GABA Receptor Agonist Drug Distributors List
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. GABA Receptor Agonist Drug Product Picture
Figure 2. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Bamaluzole Product Picture
Figure 4. Phenibut Product Picture
Figure 5. Baclofen Product Picture
Figure 6. Gaboxadol Product Picture
Figure 7. Klonopin (clonazepam) Product Picture
Figure 8. Tiagbine Product Picture
Figure 9. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Attention Deficit Hyperactivity Disorder (ADHD)
Figure 11. Psychiatric Disorders and Depression
Figure 12. Alzheimer
Figure 13. Epilepsy and Seizure
Figure 14. Anxiety and Sleep Disorders
Figure 15. Obesity and Alcoholism
Figure 16. GABA Receptor Agonist Drug Report Years Considered
Figure 17. Global GABA Receptor Agonist Drug Market Size 2015-2026 (US$ Million)
Figure 18. Global GABA Receptor Agonist Drug Sales 2015-2026 (K Pcs)
Figure 19. Global GABA Receptor Agonist Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global GABA Receptor Agonist Drug Sales Market Share by Region (2015-2020)
Figure 21. Global GABA Receptor Agonist Drug Sales Market Share by Region in 2019
Figure 22. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2015-2020)
Figure 23. Global GABA Receptor Agonist Drug Revenue Market Share by Region in 2019
Figure 24. Global GABA Receptor Agonist Drug Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by GABA Receptor Agonist Drug Revenue in 2019
Figure 26. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global GABA Receptor Agonist Drug Sales Market Share by Type (2015-2020)
Figure 28. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2019
Figure 29. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2015-2020)
Figure 30. Global GABA Receptor Agonist Drug Revenue Market Share by Type in 2019
Figure 31. Global GABA Receptor Agonist Drug Market Share by Price Range (2015-2020)
Figure 32. Global GABA Receptor Agonist Drug Sales Market Share by Application (2015-2020)
Figure 33. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2019
Figure 34. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2015-2020)
Figure 35. Global GABA Receptor Agonist Drug Revenue Market Share by Application in 2019
Figure 36. North America GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 37. North America GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America GABA Receptor Agonist Drug Sales Market Share by Country in 2019
Figure 39. North America GABA Receptor Agonist Drug Revenue Market Share by Country in 2019
Figure 40. U.S. GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. U.S. GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Canada GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America GABA Receptor Agonist Drug Market Share by Type in 2019
Figure 45. North America GABA Receptor Agonist Drug Market Share by Application in 2019
Figure 46. Europe GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 47. Europe GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe GABA Receptor Agonist Drug Sales Market Share by Country in 2019
Figure 49. Europe GABA Receptor Agonist Drug Revenue Market Share by Country in 2019
Figure 50. Germany GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Germany GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. France GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. U.K. GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Italy GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe GABA Receptor Agonist Drug Market Share by Type in 2019
Figure 61. Europe GABA Receptor Agonist Drug Market Share by Application in 2019
Figure 62. Asia Pacific GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Region in 2019
Figure 65. Asia Pacific GABA Receptor Agonist Drug Revenue Market Share by Region in 2019
Figure 66. China GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific GABA Receptor Agonist Drug Market Share by Type in 2019
Figure 89. Asia Pacific GABA Receptor Agonist Drug Market Share by Application in 2019
Figure 90. Latin America GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America GABA Receptor Agonist Drug Sales Market Share by Country in 2019
Figure 93. Latin America GABA Receptor Agonist Drug Revenue Market Share by Country in 2019
Figure 94. Mexico GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America GABA Receptor Agonist Drug Market Share by Type in 2019
Figure 101. Latin America GABA Receptor Agonist Drug Market Share by Application in 2019
Figure 102. Middle East and Africa GABA Receptor Agonist Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 103. Middle East and Africa GABA Receptor Agonist Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country in 2019
Figure 105. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Country in 2019
Figure 106. Turkey GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Turkey GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. Saudi Arabia GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E GABA Receptor Agonist Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. U.A.E GABA Receptor Agonist Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa GABA Receptor Agonist Drug Market Share by Type in 2019
Figure 113. Middle East and Africa GABA Receptor Agonist Drug Market Share by Application in 2019
Figure 114. North America GABA Receptor Agonist Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America GABA Receptor Agonist Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe GABA Receptor Agonist Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe GABA Receptor Agonist Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific GABA Receptor Agonist Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific GABA Receptor Agonist Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America GABA Receptor Agonist Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America GABA Receptor Agonist Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa GABA Receptor Agonist Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa GABA Receptor Agonist Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed

---